Who Just Raised

Sentonix, Inc.

Arlington, MA ยท Pharmaceuticals

Sentonix, Inc. is a pharmaceuticals company based in Arlington, Massachusetts. In a Form D filed with the SEC on August 20, 2026, it reported raising $12,704,719 from 17 investors as part of an offering of up to $21,203,719. The first sale in the offering took place on August 13, 2026.

60% of the $21.2M offering sold so far

Amount raised
$12,704,719
Offering size
$21,203,719
Investors so far
17
Minimum investment
$250,000
First sale
August 13, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Pharmaceuticals
Headquarters
Arlington, Massachusetts
Incorporated
Delaware, 2023
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $12,704,719 $21,203,719 17 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Massachusetts

Company Location Sector Raised Target Filed
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
Soterya, Inc. Boston, MA Health Care $850K $2M
Bioventrix, Inc. Mansfield, MA Health Care $1.2M $3M
Opus KSD, Inc. Pembroke, MA Health Care $681K $681K
Xact Bio, Inc. Boston, MA Health Care $10M $18M
Way Biosolutions, Inc. Cambridge, MA Health Care $2M $2M